BeStock  
Stocks › ARQT

Arcutis Biotherapeutics ARQT

US equityMarket cap rank #2441
$25.15 −$0.01 (-0.04%)
Pre-market · Oct 6, 7:30 am ET · After hours $25.25 +0.40%
Open$25.09
Prev close$25.16
Day range$24.69 – $25.39
Volume2.31M
Market cap$3.16B
P/E (TTM)114.3
Dividend yield–

Analyst view

ConsensusBuy
Analysts5
Average target$37.00+47.1% vs. price
  • Buy 100%
Low $34.00Now $25.15Avg $37.00High $40.00

Recent rating changes

The last 20 actions on file set price targets from $33.00 to $40.00, averaging $35.30.

DateFirmRatingTarget
10 Aug 2026 H.C. Wainwright BUY $34.00
6 Aug 2026 Morgan Stanley BUY $38.00
6 Aug 2026 Needham BUY $40.00
6 Aug 2026 H.C. Wainwright BUY $34.00
5 Aug 2026 TD Cowen BUY $35.00
5 Aug 2026 Guggenheim BUY $38.00
16 Jul 2026 Guggenheim BUY $35.00
30 Jun 2026 Needham BUY $36.00
11 May 2026 H.C. Wainwright BUY $34.00
7 May 2026 TD Cowen BUY $35.00
7 May 2026 Morgan Stanley BUY $34.00
7 May 2026 Needham BUY $36.00
7 May 2026 H.C. Wainwright BUY $34.00
23 Apr 2026 TD Cowen BUY $35.00
22 Apr 2026 Morgan Stanley BUY $35.00
15 Apr 2026 Needham BUY $36.00
2 Mar 2026 H.C. Wainwright BUY $34.00
27 Feb 2026 Goldman Sachs HOLD $33.00
26 Feb 2026 TD Cowen BUY $35.00
26 Feb 2026 Morgan Stanley BUY $35.00

Discussion

No comments yet — be the first to weigh in on ARQT.

Leave a comment

Scroll to Top